Potassium Chloride
Brand name: Klor-Con M20
Rank #102 of 500 drugs by total cost
$172.6M
Total Cost
6,137,143
Total Claims
$172.6M
Total Cost
104,442
Prescribers
$28
Cost per Claim
1,476,297
Beneficiaries
11,432,746
30-Day Fills
$1,653
Avg Cost/Provider
59
Avg Claims/Provider
About Potassium Chloride
Potassium Chloride (sold as Klor-Con M20) was prescribed 6,137,143 times by 104,442 Medicare Part D providers in 2023, costing the program $172.6M. At $28 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 99 | Omeprazole (Omeprazole) | $182.7M | 12,147,266 |
| 100 | Amlodipine Besylate (Amlodipine Besylate) | $180.1M | 20,835,727 |
| 101 | Dolutegravir Sodium/Lamivudine (Dovato) | $173.3M | 56,930 |
| 102 | Potassium Chloride (Klor-Con M20) | $172.6M | 6,137,143 |
| 103 | Darunavir/Cob/Emtri/Tenof Alaf (Symtuza) | $172.5M | 34,812 |
| 104 | Tamsulosin Hcl (Tamsulosin Hcl) | $168.5M | 8,367,036 |
| 105 | Carbidopa/Levodopa (Carbidopa-Levodopa) | $168.3M | 1,361,770 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology